Enlivex Therapeutics Ltd. (ENLV)

Enlivex Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.3	0.81	49.95	11.2	5.67
Short-Term Investments	20.2	26.51	0.3	72.93	30.03
Cash & Short-Term Investments	23.5	27.32	50.24	84.13	35.71
Cash Growth	-14.00%	-45.63%	-40.28%	135.61%	197.36%
Other Receivables	1.42	0.23	0.65	1.2	-
Receivables	1.42	0.23	0.65	1.2	-
Prepaid Expenses	0.88	1.11	1.44	1.11	1.24
Restricted Cash	-	-	-	-	1.17
Other Current Assets	0.2	5.11	-	-	-
Total Current Assets	25.99	33.76	52.33	86.44	38.12
Property, Plant & Equipment	1.15	2.58	14.9	8.22	2.14
Other Long-Term Assets	0.54	0.49	0.41	0.49	0.1
Total Assets	27.69	36.83	67.64	95.15	40.36
Accounts Payable	0.81	0.83	1.95	0.88	0.46
Accrued Expenses	2.61	3.66	4.01	3.22	2.54
Current Portion of Leases	0.24	0.35	0.65	0.62	0.2
Other Current Liabilities	0.14	1.23	-	-	1.17
Total Current Liabilities	3.8	6.06	6.61	4.72	4.37
Long-Term Leases	0.3	0.69	4.19	5.39	0.5
Total Liabilities	4.1	6.75	10.8	10.11	4.87
Common Stock	2.69	2.14	2.12	2.11	1.65
Additional Paid-In Capital	146.91	138.94	136.65	133.8	70.36
Retained Earnings	-127.11	-112.09	-83.03	-51.97	-37.5
Comprehensive Income & Other	1.1	1.1	1.1	1.1	0.98
Total Common Equity	23.59	30.08	56.84	85.04	35.49
Shareholders' Equity	23.59	30.08	56.84	85.04	35.49
Total Liabilities & Equity	27.69	36.83	67.64	95.15	40.36
Total Debt	0.53	1.03	4.85	6.01	0.7
Net Cash (Debt)	22.96	26.29	45.4	78.12	35.01
Net Cash Growth	-12.65%	-42.09%	-41.89%	123.18%	202.11%
Net Cash Per Share	1.12	1.42	2.47	4.37	2.66
Filing Date Shares Outstanding	23.65	18.6	18.42	18.37	18.31
Total Common Shares Outstanding	23.65	18.6	18.42	18.33	14.59
Working Capital	22.19	27.7	45.72	81.72	33.75
Book Value Per Share	1.00	1.62	3.09	4.64	2.43
Tangible Book Value	23.59	30.08	56.84	85.04	35.49
Tangible Book Value Per Share	1.00	1.62	3.09	4.64	2.43
Machinery	2.68	2.98	3.38	2.34	1.53
Leasehold Improvements	0.95	1.43	8.61	1.52	0.71

Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q